{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-078584","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2024-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.269739+00:00","generated_at":"2026-05-31T04:52:56.332416+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"NeuroOne amends CEO & three other execs' change-in-control severance benefits","bullets":["CEO Rosa: 2.0x base salary + 2.0x target bonus lump sum, full equity vest, 24-month COBRA upon qualifying termination.","CFO McClurg, COO Volker, CTO Mertens: 1.25x base + 1.25x bonus lump sum, full vest, 15-month COBRA.","Amendments effective Sep 9, 2024; apply to terminations within 12 months after or 3 months before a change in control.","Benefit conditioned on signing a release and ongoing compliance; all other employment terms unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-078584","json":"https://secwatch.observer/filing/0001213900-24-078584.json","markdown":"https://secwatch.observer/filing/0001213900-24-078584.md","text":"https://secwatch.observer/filing/0001213900-24-078584.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024078584/0001213900-24-078584-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024078584/ea0214149-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:52:56.332416+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}